International Biotechnology (LON:IBT) Shares Cross Above 200-Day Moving Average – Time to Sell?

Shares of International Biotechnology (LON:IBT) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 683.02 ($8.52) and traded as high as GBX 699.84 ($8.73). International Biotechnology shares last traded at GBX 692 ($8.63), with a volume of 53,428 shares trading hands.

International Biotechnology Price Performance

The firm has a 50 day moving average price of GBX 694.62 and a 200 day moving average price of GBX 683.02. The stock has a market capitalization of £257.00 million, a PE ratio of 1,448.63 and a beta of 0.21. The company has a current ratio of 0.46, a quick ratio of 0.32 and a debt-to-equity ratio of 9.66.

International Biotechnology Increases Dividend

The company also recently declared a dividend, which will be paid on Friday, January 24th. Shareholders of record on Thursday, December 19th will be given a GBX 15.56 ($0.19) dividend. This is a positive change from International Biotechnology’s previous dividend of $14.50. This represents a dividend yield of 2.21%. The ex-dividend date is Thursday, December 19th. International Biotechnology’s dividend payout ratio is presently 6,041.67%.

Insider Transactions at International Biotechnology

In other International Biotechnology news, insider Katherine Cornish-Bowden acquired 1,500 shares of the company’s stock in a transaction dated Tuesday, December 17th. The stock was purchased at an average price of GBX 713 ($8.89) per share, with a total value of £10,695 ($13,342.07). Corporate insiders own 4.18% of the company’s stock.

International Biotechnology Company Profile

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.